MediFind
Condition

Buerger Disease

Symptoms, Doctors, Treatments, Research & More

Find a Doctor

Yasuki Kihara

Hiroshima University Graduate School Of Biomedical And Health Sciences

Bio


Yasuki Kihara is in Hiroshima, Japan. Dr. Kihara is a global expert in Buerger Disease. They have been an author on 420 peer reviewed articles in the past 15 years. In particular, they have been an author on 9 peer reviewed articles regarding Buerger Disease. Dr. Kihara's top three areas of expertise are Buerger Disease, Thromboangiitis Obliterans, and Atherosclerosis.

Contact

Hiroshima, JP

Latest Research


Latest Advance
Study
  • Condition: Atrial fibrillation
  • Journal: Thrombosis research
  • Treatment Used: Direct oral anticoagulants
  • Number of Patients: 102
  • Published —
The study researched the after-effects of stopping direct oral anticoagulants (blood thinners) for atrial fibrillation.
Latest Advance
Study
  • Condition: Chronic Heart Failure
  • Journal: Circulation journal : official journal of the Japanese Circulation Society
  • Treatment Used: Ivabradine
  • Number of Patients: 127
  • Published —
This study evaluated the effectiveness and safety of ivabradine in Japanese patients with chronic heart failure.
Latest Advance
Study
  • Condition: Hypertensive Patients with Type 2 Diabetes Mellitus
  • Journal: American journal of hypertension
  • Treatment Used: Alogliptin
  • Number of Patients: 22
  • Published —
The study researched the effects of alogliptin in treating hypertensive patients with type 2 diabetes mellitus.
Latest Advance
Study
  • Condition: Idiopathic hyperaldosteronism
  • Journal: Journal of hypertension
  • Treatment Used: Eplerenone
  • Number of Patients: 50
  • Published —
The study researched the use of Eplerenone in patients with idiopathic hyperaldosteronism.
Latest Advance
Study
  • Condition: Living-donor Kidney Transplantation
  • Journal: Transplantation proceedings
  • Treatment Used: immunosuppression therapy induction with tacrolimus extended-release versus cyclosporine
  • Number of Patients: 83
  • Published —
The purpose of the study was to determine the effectiveness of extended-release tacrolimus versus cyclosporine therapy for immunosuppression induction after living-donor kidney transplants.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: Circulation journal : official journal of the Japanese Circulation Society
  • Published —
Japanese Heart Failure Society 2018 Scientific Statement on Nutritional Assessment and Management in Heart Failure Patients.

Contact

Hiroshima, JP

Insurance

Contact them to find out if they accept your insurance plan.